David Scott Miller


AuthID: R-00K-250

Confirmed Publications: 294



21
TITLE: 20MO Time to deterioration in quality of life in patients (pts) with advanced endometrial cancer (aEC) treated with lenvatinib plus pembrolizumab (L+P) or treatment of physician’s choice (TPC)
AUTHORS: Lorusso, D; Colombo, N; Casado Herraez, A; A.D Santin; Colomba, E; David Scott Miller ; Fujiwara, K; Pignata, S; S.E Baron-Hay; I.L Ray-Coquard; Shapira-Frommer, R; Y.M Kim; McCormack, M; Massaad, R; Martin Nguyen, A; Zhao, Q; McKenzie, J; V.S Prabhu; Makker, V;
PUBLISHED: 2022, SOURCE: Annals of Oncology, VOLUME: 33
INDEXED IN: CrossRef: 1
IN MY: ORCID | CIÊNCIAVITAE
22
TITLE: 45 Disparities in carcinosarcoma: public vs private hospital system
AUTHORS: Larissa Aroche-Gutierrez; Donald D McIntire; Jayanthi Lea; Salvatore LoCoco; Matthew Carlson; David Scott Miller ;
PUBLISHED: 2022, SOURCE: Gynecologic Oncology Reports, VOLUME: 44
INDEXED IN: CrossRef
IN MY: ORCID | CIÊNCIAVITAE
23
TITLE: 525MO Updated efficacy and safety of lenvatinib (LEN) + pembrolizumab (pembro) vs treatment of physician’s choice (TPC) in patients (pts) with advanced endometrial cancer (aEC): Study 309/KEYNOTE-775
AUTHORS: Makker, V; Colombo, N; Casado Herraez, A; B.J Monk; Mackay, H; A.D Santin; David Scott Miller ; R.G Moore; S.E Baron-Hay; I.L Ray-Coquard; Shapira-Frommer, R; Ushijima, K; Yonemori, K; Y.M Kim; E.M Guerra Alia; U.A Sanli; Huang, J; McKenzie, J; Barresi, G; Lorusso, D;
PUBLISHED: 2022, SOURCE: Annals of Oncology, VOLUME: 33
INDEXED IN: CrossRef: 1
IN MY: ORCID | CIÊNCIAVITAE
24
TITLE: A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study  Full Text
AUTHORS: Brian M Slomovitz; Virginia L Filiaci; Joan L Walker; Michael C Taub; Karen A Finkelstein; John W Moroney; Aimee C Fleury; Carolyn Y Muller; Laura L Holman; Larry J Copeland; David Scott Miller ; Robert L Coleman;
PUBLISHED: 2022, SOURCE: Gynecologic Oncology, VOLUME: 164, ISSUE: 3
INDEXED IN: Scopus CrossRef: 19
IN MY: ORCID | CIÊNCIAVITAE
25
TITLE: Efficacy of next line of therapy after treatment with lenvatinib (LEN) in combination with pembrolizumab (pembro) versus treatment of physician’s choice (TPC) in patients (pts) with advanced endometrial cancer (aEC): Exploratory analysis of Study 309/KEYNOTE-775.
AUTHORS: Vicky Makker; Nicoletta Colombo; Alessandro Santin; David Scott Miller ; Keiichi Fujiwara; Sandro Pignata; Isabelle Laure Ray-Coquard; Yong Man Kim; Eva M Guerra; Jie Huang; Gianmaria Barresi; Jodi McKenzie; Domenica Lorusso;
PUBLISHED: 2022, SOURCE: Journal of Clinical Oncology, VOLUME: 40, ISSUE: 16_suppl
INDEXED IN: CrossRef: 1
IN MY: ORCID | CIÊNCIAVITAE
26
TITLE: Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study  Full Text
AUTHORS: Yovanni Casablanca; Guisong Wang; Heather A Lankes; Chunqiao Tian; Nicholas W Bateman; Caela R Miller; Nicole P Chappell; Laura J Havrilesky; Amy Hooks Wallace; Nilsa C Ramirez; David Scott Miller ; Julie Oliver; Dave Mitchell; Tracy Litzi; Brian E Blanton; William J Lowery; John I Risinger; Chad A Hamilton; Neil T Phippen; Thomas P Conrads; David Mutch; Katherine Moxley; Roger B Lee; Floor Backes; Michael J Birrer; Kathleen M Darcy; George Larry Maxwell; ...More
PUBLISHED: 2022, SOURCE: Cancers, VOLUME: 14, ISSUE: 17
INDEXED IN: Scopus CrossRef: 1 Unpaywall
IN MY: ORCID | CIÊNCIAVITAE
27
TITLE: Isolated para-aortic nodal metastasis or recurrence absent after radical hysterectomy for stage IA-IIA cervical carcinoma (401)  Full Text
AUTHORS: Steven Holloway; Alyssa Mercadel; David Scott Miller ; Jayanthi Lea;
PUBLISHED: 2022, SOURCE: Gynecologic Oncology, VOLUME: 166
INDEXED IN: CrossRef
IN MY: ORCID | CIÊNCIAVITAE
28
TITLE: Lenvatinib Plus Pembrolizumab for Advanced Endometrial Cancer
AUTHORS: Vicky Makker; Nicoletta Colombo; Antonio Casado Herráez; Alessandro D Santin; Emeline Colomba; David Scott Miller ; Keiichi Fujiwara; Sandro Pignata; Sally Baron Hay; Isabelle Ray Coquard; Ronnie Shapira Frommer; Kimio Ushijima; Jun Sakata; Kan Yonemori; Yong Man Kim; Eva M Guerra; Ulus A Sanli; Mary M McCormack; Alan D Smith; Stephen Keefe; Steven Bird; Lea Dutta; Robert J Orlowski; Domenica Lorusso; ...More
PUBLISHED: 2022, SOURCE: Journal of Bone and Joint Surgery, VOLUME: 77, ISSUE: 5
INDEXED IN: Scopus CrossRef
IN MY: ORCID | CIÊNCIAVITAE
29
TITLE: Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
AUTHORS: Makker V.; Colombo N.; Casado C Herráez; Santin A.D.; Colomba E.; David Scott Miller ; Fujiwara K.; Pignata S.; Baron-Hay S.; Ray-Coquard I.; Shapira-Frommer R.; Ushijima K.; Sakata J.; Yonemori K.; Kim Y.M.; Guerra E.M.; Sanli U.A.; McCormack M.M.; Smith A.D.; Keefe S.; Bird S.; Dutta L.; Orlowski R.J.; Lorusso D.; ...More
PUBLISHED: 2022, SOURCE: New England Journal of Medicine, VOLUME: 386, ISSUE: 5
INDEXED IN: Scopus CrossRef: 359
IN MY: ORCID | CIÊNCIAVITAE
30
TITLE: Lynch Syndrome Identification in Endometrial Cancer Patients: Should Universal Screening be Used for all Histologies?
AUTHORS: Jessica E Parker; Caitlin Mauer; Wenxin Zheng; David Scott Miller ; Jayanthi S Lea;
PUBLISHED: 2022, SOURCE: Current Women's Health Reviews, VOLUME: 18, ISSUE: 2
INDEXED IN: Scopus CrossRef
IN MY: ORCID | CIÊNCIAVITAE
Page 3 of 30. Total results: 294.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service